Improving the clarity and transparency of reporting health research: a shared obligation and responsibility.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 18809741)

Published in J Dent Res on October 01, 2008

Authors

I Needleman, D Moher, D G Altman, K F Schulz, D R Moles, H Worthington

Articles by these authors

Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41

The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70

Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA (1996) 36.04

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74

Measuring agreement in method comparison studies. Stat Methods Med Res (1999) 31.11

Multiple significance tests: the Bonferroni method. BMJ (1995) 23.46

Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA (2001) 19.20

Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) (1986) 18.51

Analysis of serial measurements in medical research. BMJ (1990) 16.69

A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev (2007) 14.60

Cronbach's alpha. BMJ (1997) 13.79

The scandal of poor medical research. BMJ (1994) 11.58

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med (2001) 11.48

Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90

Statistics notes. Logarithms. BMJ (1996) 10.56

Statistics in medical journals. Stat Med (1983) 9.80

Evaluating non-randomised intervention studies. Health Technol Assess (2003) 9.69

Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet (1995) 9.14

Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ (2001) 8.98

Statistics and ethics in medical research: III How large a sample? Br Med J (1980) 8.78

Better reporting of randomised controlled trials: the CONSORT statement. BMJ (1996) 8.39

More informative abstracts revisited. Ann Intern Med (1990) 8.26

Transforming data. BMJ (1996) 6.78

Regression towards the mean. BMJ (1994) 6.57

Measurement error. BMJ (1996) 6.18

Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA (1994) 5.80

Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67

Statistics notes. The odds ratio. BMJ (2000) 5.61

The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol (2001) 5.43

Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol (2003) 5.40

How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing. Lancet (1999) 5.27

Statistics notes. Interaction 2: Compare effect sizes not P values. BMJ (1996) 5.18

Correlation, regression, and repeated data. BMJ (1994) 4.88

Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects. BMJ (1995) 4.87

REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85

Social factors and height of primary schoolchildren in England and Scotland. J Epidemiol Community Health (1978) 4.73

Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA (1998) 4.73

Randomisation. BMJ (1991) 4.66

Patients' preferences and randomised trials. Lancet (1996) 4.64

Measurement error and correlation coefficients. BMJ (1996) 4.38

Indirect comparisons of competing interventions. Health Technol Assess (2005) 4.33

Statistical aspects of prognostic factor studies in oncology. Br J Cancer (1994) 4.22

Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet (2000) 4.16

Measurement error. BMJ (1996) 4.13

Survival analysis part I: basic concepts and first analyses. Br J Cancer (2003) 4.08

Some examples of regression towards the mean. BMJ (1994) 4.01

Redundancy, disaggregation, and the integrity of medical research. Lancet (1996) 3.99

Survival probabilities (the Kaplan-Meier method). BMJ (1998) 3.98

The influence of varying maxillary lateral incisor dimensions on perceived smile aesthetics. Br Dent J (2007) 3.85

Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol (2007) 3.84

A catalogue of reporting guidelines for health research. Eur J Clin Invest (2010) 3.83

Effects of a drug overdose in a television drama on presentations to hospital for self poisoning: time series and questionnaire study. BMJ (1999) 3.52

Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ (2011) 3.50

The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43

Transformations, means, and confidence intervals. BMJ (1996) 3.42

What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol (2000) 3.37

Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ (1995) 3.35

Measurement error proportional to the mean. BMJ (1996) 3.34

The effectiveness of glucocorticoids in treating croup: meta-analysis. BMJ (1999) 3.25

National study of health and growth: standards of attained height, weight and triceps skinfold in English children 5 to 11 years old. Ann Hum Biol (1977) 3.23

The use of transformation when comparing two means. BMJ (1996) 3.22

A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med (1990) 3.18

Interaction 3: How to examine heterogeneity. BMJ (1996) 3.17

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ (2011) 3.17

Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer (2004) 3.15

Survival analysis part II: multivariate data analysis--an introduction to concepts and methods. Br J Cancer (2003) 3.06

Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ (1996) 2.99

Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects. BMJ (1995) 2.94

Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units. BMJ (1998) 2.94

Outcome selection bias in meta-analysis. Stat Methods Med Res (2005) 2.86

Statistics and ethics in medical research. VI--Presentation of results. Br Med J (1980) 2.85

The effects of combining education and enforcement to reduce tobacco sales to minors. A study of four northern California communities. JAMA (1991) 2.77

A prognostic model for ovarian cancer. Br J Cancer (2001) 2.77

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ (2001) 2.74

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Podiatr Med Assoc (2001) 2.71

Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit. Br J Cancer (2003) 2.71

Baseline comparisons in randomized clinical trials. Stat Med (1991) 2.69

Predictors of physician's smoking cessation advice. JAMA (1991) 2.66

More informative abstracts. Ann Intern Med (1987) 2.63

Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet (2001) 2.61

One and two sided tests of significance. BMJ (1994) 2.61

Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev (2005) 2.41

Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet (2001) 2.35

The effectiveness of manual versus powered toothbrushes for dental health: a systematic review. J Dent (2004) 2.29

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer (1991) 2.29

The efficacy of problem-solving treatments after deliberate self-harm: meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems. Psychol Med (2001) 2.22

Statistics notes: blinding in clinical trials and other studies. BMJ (2000) 2.17

Randomized controlled trials of home uterine activity monitoring: a review and critique. Obstet Gynecol (1992) 2.14